These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 865186)

  • 61. Antirheumatic effect of pirfenidone in a double blind clinical pilot trial in humans.
    Pesce E; Struma E; Giri SN; Margolin SB
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():39-48. PubMed ID: 17564304
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Further contributions on the therapeutic action of Febutol in ORL].
    Perrella F; Alinei D
    Minerva Otorinolaringol; 1968; 18(2):94-8. PubMed ID: 5741565
    [No Abstract]   [Full Text] [Related]  

  • 63. [Pulmonary toxicity associated with treatment by gold salts].
    Ballesteros JA; Maimó A; Usandizaga I; Orfila J
    Med Clin (Barc); 1995 Jan; 104(2):78-9. PubMed ID: 7869784
    [No Abstract]   [Full Text] [Related]  

  • 64. Paraquat poisoning. Serial studies of lung function.
    Cooke NJ; Flenley DC; Matthew H
    Q J Med; 1973 Oct; 42(168):683-92. PubMed ID: 4606886
    [No Abstract]   [Full Text] [Related]  

  • 65. Ulcer of the cecum during oxyphenbutazone (tandearil) therapy.
    Debenham GP
    Can Med Assoc J; 1966 May; 94(22):1182-4. PubMed ID: 5934387
    [No Abstract]   [Full Text] [Related]  

  • 66. Oxyphenbutazone-induced parotitis.
    Gross L
    Ann Intern Med; 1969 Jun; 70(6):1229-30. PubMed ID: 5789512
    [No Abstract]   [Full Text] [Related]  

  • 67. [Pulmonary berylliosis].
    Saxén L; Pasila M
    Duodecim; 1978; 94(8):504-8. PubMed ID: 648427
    [No Abstract]   [Full Text] [Related]  

  • 68. Fixed eruption due to two unrelated drugs: oxyphenbutazone and tetracycline.
    Bhargava NC; Singh G
    Int J Dermatol; 1981; 20(6):435. PubMed ID: 6455387
    [No Abstract]   [Full Text] [Related]  

  • 69. Thrombocytopenia and L.E. cells after oxyphenbutazone.
    Handley AJ
    Lancet; 1971 Jan; 1(7692):245-6. PubMed ID: 4099912
    [No Abstract]   [Full Text] [Related]  

  • 70. Amegakaryocytic thrombocytopenia and an analgesic.
    Font J; Nomdedeu B; Martinez-Orozco F; Ingelmo M; Balcells A
    Ann Intern Med; 1981 Dec; 95(6):783. PubMed ID: 7305167
    [No Abstract]   [Full Text] [Related]  

  • 71. [Lung manifestations after salazopyrinine intake].
    Rosenhall L; Uddenfeldt M
    Lakartidningen; 1979 Oct; 76(44):3923-4. PubMed ID: 43440
    [No Abstract]   [Full Text] [Related]  

  • 72. Double-blind clinical trial of protacine versus oxyphenbutazone in rheumatic disorders.
    Loizzi P; Pipitone V; Bignamini AA
    Pharmatherapeutica; 1980; 2(5):285-92. PubMed ID: 7001487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pulmonary adverse effects of oxyphenbutazone].
    Lakartidningen; 1977 May; 74(21):2109. PubMed ID: 865186
    [No Abstract]   [Full Text] [Related]  

  • 74. Letter: diffuse pulmonary disorder caused by oxyphenbutazone.
    Cameron DC
    Br Med J; 1975 May; 2(5969):500-1. PubMed ID: 1148675
    [No Abstract]   [Full Text] [Related]  

  • 75. [Effect of oxyphenbutazone on radiation-induced lung diseases].
    Müller-Fassbender H; Klein U; Bablath H; Heinze HG
    Med Klin; 1973 Apr; 68(15):478-83. PubMed ID: 4696892
    [No Abstract]   [Full Text] [Related]  

  • 76. [Clinical experiences with realin (oxyphenbutazone and prednisolone) in progressive chronic polyarthritis].
    Klein G; Fellner S
    Z Rheumaforsch; 1973; 32(7):302-5. PubMed ID: 4741803
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.